Performance of Non-Invasive Monitors During ANH



Status:Not yet recruiting
Healthy:No
Age Range:18 - 70
Updated:3/3/2019
Start Date:November 2019
End Date:November 2019
Contact:Neal W Fleming, M.D., Ph.D.
Email:nwfleming@ucdavis.edu
Phone:916-734-5046

Use our guide to learn which trials are right for you!

The Evaluation of Minimally Invasive Hemodynamic Monitors for the Assessment of Volume Responsiveness to Various Standard Replacement Fluids During Acute Normovolemic Hemodilution

The aim of this study is to assess the responsiveness of the standard minimally invasive
hemodynamic monitors used in the operating room to known changes in the intravascular volume
status that occur during blood removal and volume replacement with three different standard
fluids used during ANH.


Inclusion Criteria:

- Those surgical procedures where ANH is included in the surgical plan and consent is
obtained

Exclusion Criteria:

- Severe or symptomatic COPD, emphysema, renal, hepatic or coronary artery disease as
defined by the American College of Cardiology (Cannon et al., 2001).

- Esophageal pathology (diverticulum, hiatal hernia, esophageal cancer, esophageal
surgery), which introduces risks associated with the placement of the esophageal
Doppler.

- Ascites.

- BMI >35

- Pregnancy
We found this trial at
1
site
Sacramento, California 95817
Phone: 916-690-3956
?
mi
from
Sacramento, CA
Click here to add this to my saved trials